Novo Nordisk Aktie
40,32
EUR
-0,84
EUR
-2,03
%
40,20
EUR
-1,02
EUR
-2,47
%
Werbung
Novo Nordisk Aktie Analyse
| 15.04.20 | Novo Nordisk buy | UBS AG | |
| 15.04.20 | Novo Nordisk Outperform | Bernstein Research | |
| 14.04.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 09.04.20 | Novo Nordisk overweight | Barclays Capital | |
| 07.04.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.03.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 23.03.20 | Novo Nordisk buy | UBS AG | |
| 18.03.20 | Novo Nordisk Outperform | Bernstein Research | |
|
Werbung
|
|||
| 17.03.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 17.03.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 17.03.20 | Novo Nordisk overweight | Barclays Capital | |
| 02.03.20 | Novo Nordisk overweight | Barclays Capital | |
| 25.02.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 06.02.20 | Novo Nordisk Outperform | Credit Suisse Group | |
| 06.02.20 | Novo Nordisk overweight | Barclays Capital | |
| 06.02.20 | Novo Nordisk Outperform | Bernstein Research | |
| 06.02.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 06.02.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 05.02.20 | Novo Nordisk overweight | Barclays Capital | |
| 05.02.20 | Novo Nordisk Outperform | Bernstein Research | |
| 05.02.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 31.01.20 | Novo Nordisk overweight | Barclays Capital | |
| 29.01.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 27.01.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 20.01.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 17.01.20 | Novo Nordisk overweight | Barclays Capital | |
| 17.01.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 16.01.20 | Novo Nordisk overweight | Barclays Capital | |
| 16.01.20 | Novo Nordisk Outperform | Credit Suisse Group | |
| 06.01.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 06.01.20 | Novo Nordisk kaufen | Bernstein Research | |
| 21.11.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.11.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 18.11.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 18.11.19 | Novo Nordisk overweight | Barclays Capital | |
| 06.11.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.11.19 | Novo Nordisk Outperform | Credit Suisse Group | |
| 04.11.19 | Novo Nordisk Outperform | Bernstein Research | |
| 04.11.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 01.11.19 | Novo Nordisk buy | UBS AG | |
| 01.11.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 28.10.19 | Novo Nordisk Outperform | Credit Suisse Group | |
| 21.10.19 | Novo Nordisk buy | UBS AG | |
| 09.10.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.10.19 | Novo Nordisk Outperform | Credit Suisse Group | |
| 23.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 20.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 19.09.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 18.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 12.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
Werbung
Werbung